Figure 3From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma Kaplan-Meier analysis of disease-free survival (DFS) in patients based on their response to treatment. Back to article page